Glaukos to join S&P SmallCap 600, potential near-term liquidity boost
Oct 30, 2026, 7:12 PM EDT1 sourcesAI-analyzed
Why it may matterVerify against the original reporting
Index rebalances typically create short-term demand for added components via index funds and ETFs; GKOS entering a broader SmallCap 600 investing universe can lift liquidity and invite rebalancing-driven buying, despite a mid-cap exit that may otherwise pressure price.
AI summary
What happened, with direct paths to the underlying reporting
Glaukos GKOS will be removed from the S&P MidCap 400 and added to the S&P SmallCap 600 on November 4, 2026, as part of the index reconstitution. The shift may boost GKOS liquidity through passive index buying while potentially elevating volatility around the effective date. Okta moves to the S&P 500, MGRC enters the SmallCap 600, and KVUE's status shifts due to a related acquisition.
GKOS exits S&P MidCap 400 and enters S&P SmallCap 600.
MGRC replaces GKOS in the SmallCap 600; GKOS moves down a tier.
Okta moves into the S&P 500; KVUE is deleted from the index.
KMB to acquire KVUE; deal closing conditions pending.
Loar Holdings replaces LiveRamp in the SmallCap 600.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.
Related signals
More source-backed signals connected by company or event
Glaukos reported a robust Q3 with revenue of $211.03 million, well above consensus at $168.22 million, and non-GAAP EPS of $0.47 versus an expected loss of $0.10. The company also…
Glaukos announced topline Phase 4 results for iDose TR used with cataract surgery, showing better diurnal IOP reduction than cataract surgery alone (11.1 mmHg vs 7.4 mmHg at three…
Glaukos reports three-year durability for its keratoconus therapy, with patients retaining vision and corneal shape after a single treatment. The durability data strengthen the ca…
Glaukos Corp (NYSE: GKOS) announced its fourth-quarter earnings, which were mixed and could impact investor sentiment. Uncertainty surrounding future growth and performance may pr…